Home > Boards > US Listed > Biotechs > Moderna Inc. (MRNA)

BioNTech Teams up With Sanofi to Target Solid

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Trend-Setter Member Profile
 
Followed By 4
Posts 707
Boards Moderated 0
Alias Born 07/19/13
160x600 placeholder
Moderna to Present Data From Two of Its Prophylactic mRNA Vaccines at IDWeek 2019 Business Wire - 10/2/2019 7:00:00 AM
Moderna Announces Open IND for Propionic Acidemia Program (mRNA-3927) Business Wire - 9/30/2019 8:00:00 AM
Moderna Announces mRNA Immunotherapy Research Collaboration with Harvard University Business Wire - 9/26/2019 8:00:00 AM
Moderna to Present at Upcoming Investor Conferences Business Wire - 9/25/2019 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/18/2019 4:12:28 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/12/2019 7:03:06 AM
Moderna Announces Positive Phase 1 Results for the First Systemic Messenger RNA Therapeutic Encoding a Secreted Protein (mRNA... Business Wire - 9/12/2019 6:31:00 AM
Moderna Announces Positive Interim Results from Phase 1 Cytomegalovirus (CMV) Vaccine (mRNA-1647) Study & Progress Toward Pha... Business Wire - 9/12/2019 6:30:00 AM
Moderna Appoints Tracey Franklin as Chief Human Resources Officer Business Wire - 9/4/2019 8:00:00 AM
Moderna to Host R&D Day on September 12, 2019 Business Wire - 8/29/2019 8:00:00 AM
Moderna to Present at Upcoming Investor Conferences Business Wire - 8/27/2019 8:00:00 AM
Moderna Receives FDA Fast Track Designation for Zika Vaccine mRNA-1893 Business Wire - 8/19/2019 4:01:00 PM
Moderna Provides Business Updates and Reports Second Quarter 2019 Financial Results Business Wire - 8/7/2019 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/7/2019 6:58:27 AM
Moderna to Report Second Quarter 2019 Financial Results on Wednesday, August 7th, 2019 Business Wire - 7/24/2019 8:00:00 AM
Moderna to Present at ROTH RNA Revolution Conference Business Wire - 7/10/2019 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/28/2019 4:36:14 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/28/2019 4:34:32 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/28/2019 4:32:04 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/28/2019 4:29:39 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/28/2019 4:17:31 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/28/2019 4:15:36 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/28/2019 4:13:45 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/28/2019 4:12:20 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/27/2019 4:07:27 PM
Trend-Setter   Friday, 01/04/19 12:39:51 PM
Re: None
Post # of 35 
BioNTech Teams up With Sanofi to Target Solid Tumors in $91.5 Million Deal...

As part of the deal, the French pharma giant will invest about $91.5 million in equity in BioNTech, a privately-held company. The investment follows BioNTech’s 2018 decision to exercise one of the option rights under the 2015 agreement to co-develop and co-commercialize the immuno-oncology candidate. The two companies will work to develop an investigational therapy that includes an mRNA mixture encoding immunomodulatory cytokines that are injected directly into the tumor. Local administration of immunotherapies to the tumor microenvironment provides the opportunity to stimulate innate and adaptive immune responses against tumors, while potentially avoiding toxicities related to systemic administration of immuno-modulatory therapeutics.

https://www.biospace.com/article/biontech-teams-up-with-sanofi-to-target-solid-tumors-in-91-5-million-deal/

Looks like mRNA based vaccines for immunotherapies is the new trend in fighting cancers and infectious diseases.

Although this new comer is still in its infancy, I think there is great potential in this space. imo

GL

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist